Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. (Record no. 9934668)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02126 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513163705.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199902s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0270-4137 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/(sici)1097-0045(19990101)38:1<73::aid-pros9>3.0.co;2-v |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Murphy, G P |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19990223 |
| 245 00 - TITLE STATEMENT | |
| Title | Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Prostate |
| Date of publication, distribution, etc. | Jan 1999 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 73-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antigens, Neoplasm |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antigens, Surface |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bone Neoplasms |
| General subdivision | diagnostic imaging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer Vaccines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carboxypeptidases |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dendritic Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glutamate Carboxypeptidase II |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HLA-A2 Antigen |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hormones |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prostatic Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radionuclide Imaging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vaccines, Synthetic |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tjoa, B A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Simmons, S J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jarisch, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bowes, V A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ragde, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rogers, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elgamal, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kenny, G M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cobb, O E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ireton, R C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Troychak, M J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salgaller, M L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boynton, A L |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Prostate |
| Related parts | vol. 38 |
| -- | no. 1 |
| -- | p. 73-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/(sici)1097-0045(19990101)38:1<73::aid-pros9>3.0.co;2-v">https://doi.org/10.1002/(sici)1097-0045(19990101)38:1<73::aid-pros9>3.0.co;2-v</a> |
| Public note | Available from publisher's website |
No items available.